Back to search
Vitrification
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vitrification trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vitrification trials you may qualify forOocyte vitrification is an effective method of freezing which has been authorized in France since 2011. The arrival of this technique has led to real improvemen…
One of the barriers in patients with diminished ovarian reserve (DOR) is the significantly reduced number of oocytes resulting in fewer oocytes collected and em…
Purpose: This study aims to test whether a new automated system can freeze human eggs and embryos as effectively as the current manual method performed by labor…
The multi-step thawing protocol with a reduction of non-permeable cryoprotectant concentrations to reduce osmotic shock caused by the rapid influx of water. Rec…
This study will recruit 260 female recipients (and up to a maximum of 130 donors). This study is a sequel to the protocol CP-DV-000-GEN-003, entitled, "NON-INFE…
Proper chromosome segregation is essential to avoid aneuploidy, yet in mammalian oocytes it progressively fails in an age-dependent manner. The ageing populatio…
Blastocyst vitrification is standard in assisted reproduction, but clinical data on ultra-rapid vitrification are limited. This pilot study evaluates the safety…
The present investigation aims to evaluate the efficacy of an innovative protocol of controlled ovarian stimulation for breast cancer patients, who are candidat…
Vitrification has become the gold standard for oocyte and embryo cryopreservation. Several commercial kits are available on the market, some are designed for sp…